76 related articles for article (PubMed ID: 1865503)
1. Measures of renal function in patients with cisplatin-related chronic renal disease.
Reed E; Jacob J; Brawley O
J Natl Med Assoc; 1991 Jun; 83(6):522-6. PubMed ID: 1865503
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature.
Finco DR; Duncan JR
J Am Vet Med Assoc; 1976 Apr; 168(7):593-601. PubMed ID: 1270342
[TBL] [Abstract][Full Text] [Related]
3. Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity.
Reece PA; Stafford I; Russell J; Khan M; Gill PG
J Clin Oncol; 1987 Feb; 5(2):304-9. PubMed ID: 3806171
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin nephrotoxicity in a patient with a single kidney.
Udeani GO; Singh K; Mullane MR; Lad TE
Ann Pharmacother; 1996; 30(7-8):782-6. PubMed ID: 8826561
[TBL] [Abstract][Full Text] [Related]
5. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.
Campbell AB; Kalman SM; Jacobs C
Cancer Treat Rep; 1983 Feb; 67(2):169-72. PubMed ID: 6681731
[TBL] [Abstract][Full Text] [Related]
6. Safe, rapid administration of cisplatin in the outpatient clinic.
Brock J; Alberts DS
Cancer Treat Rep; 1986 Dec; 70(12):1409-14. PubMed ID: 3539327
[TBL] [Abstract][Full Text] [Related]
7. Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man.
Dentino M; Luft FC; Yum MN; Williams SD; Einhorn LH
Cancer; 1978 Apr; 41(4):1274-81. PubMed ID: 638991
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observations.
Canpolat C; Pearson P; Robertson R; Jaffe N
Med Pediatr Oncol; 1996 Jan; 26(1):36-47. PubMed ID: 7494510
[TBL] [Abstract][Full Text] [Related]
9. Effect of repeated oral administrations of the oral adsorbent AST-120 on serum creatinine and other markers of renal function. A randomized controlled study in patients with chronic kidney disease.
Marier JF; Lee J; Kambhampati SR; Galitz L; Vargas R; Moberly J; Salazar DE
Am J Nephrol; 2006; 26(2):136-41. PubMed ID: 16549905
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.
Ogilvie GK; Fettman MJ; Jameson VJ; Walters LM; Lafferty MH; Cooper MF; Powers BE; Ciekot PA; Atwater SW; Withrow SJ
Am J Vet Res; 1992 Sep; 53(9):1666-9. PubMed ID: 1416374
[TBL] [Abstract][Full Text] [Related]
11. Inadequacy of predicted creatinine clearance as guide to chemotherapy.
McDermott DF; Galindo A; Sherman RL; Jaffe EA; Coleman M; Pasmantier MW
Cancer Treat Rep; 1987 Nov; 71(11):1067-9. PubMed ID: 3677111
[TBL] [Abstract][Full Text] [Related]
12. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
Hans SS; Hans BA; Dhillon R; Dmuchowski C; Glover J
Am Surg; 1998 May; 64(5):432-6. PubMed ID: 9585778
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
Pili-Floury S; Royer B; Bartholin F; Crumiere N; Combe M; Chalopin JM; Pivot X; Heyd B; Chauffert B; Samain E
Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):199-203. PubMed ID: 21306815
[TBL] [Abstract][Full Text] [Related]
14. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
[TBL] [Abstract][Full Text] [Related]
15. Clinically silent progressive renal tubulointerstitial disease during cisplatin chemotherapy.
Guinee DG; van Zee B; Houghton DC
Cancer; 1993 Jun; 71(12):4050-4. PubMed ID: 8508369
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of low dose aspirin in elderly patients.
Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
[TBL] [Abstract][Full Text] [Related]
17. Renal function trajectories and clinical outcomes in acute heart failure.
Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA
Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137
[TBL] [Abstract][Full Text] [Related]
18. Low nitric oxide production in patients with chronic renal failure.
Blum M; Yachnin T; Wollman Y; Chernihovsky T; Peer G; Grosskopf I; Kaplan E; Silverberg D; Cabili S; Iaina A
Nephron; 1998; 79(3):265-8. PubMed ID: 9678424
[TBL] [Abstract][Full Text] [Related]
19. [Cisplatin-induced nephrotoxic side effects of cytostatic chemotherapy of testicular tumors].
Rebmann U; Oehlmann U; Warnack W
Z Exp Chir Transplant Kunstliche Organe; 1990; 23(2):83-5. PubMed ID: 1703720
[TBL] [Abstract][Full Text] [Related]
20. Cis-dichlorodiammine platinum (II) in advanced ovarian carcinoma.
Stewart JF; Tattersall MH; Woods RL; Fox RM
Med J Aust; 1979 Jun; 1(12):548-50. PubMed ID: 470725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
